Aptevo Therapeutics Inc. 8-K

What Happened

• Aptevo Therapeutics Inc. announced its financial results for the period ended March 31, 2026 via a press release dated May 13, 2026. The company filed Form 8‑K (Item 2.02) to furnish that press release (Exhibit 99.1). The 8‑K states the information is being furnished—not filed—and therefore is not subject to certain securities‑act liabilities.

Key Details

• Item reported: 2.02 (Results of Operations and Financial Condition).
• Press release date: May 13, 2026; reporting period: quarter ended March 31, 2026.
• Exhibit included: 99.1 (press release).
• Filing signed by Daphne Taylor, Senior Vice President and Chief Financial Officer.
• The filing explicitly notes the furnished information will not be incorporated by reference into other SEC filings unless expressly stated.

Why It Matters

• This filing notifies investors that Aptevo has released its quarterly earnings and related financial information; investors should read the attached press release (Exhibit 99.1) to see revenue, earnings, cash position, and any commentary on guidance or operations.
• Because the release is furnished (not filed), it carries different legal protections and is generally not subject to the same liabilities as filed statements—important when assessing disclosures.
• Retail investors should check the press release and any subsequent SEC filings (e.g., 10‑Q) for full financial details and context.